Search
Back

Ferric Citrate

CAS 2338-05-8
Ferric Citrate

General Information

Fexeric is indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD).


About the API

Technology Synthetic
Therapeutic category Hematology
Available formulations Oral Solid
Regulations
  • Japan DMF
  • Korea DMF
  • US DMF

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources.

For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.